Cite
Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy.
MLA
Eichholz, Thomas, et al. “Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy.” Pediatric Infectious Disease Journal, vol. 41, no. 6, June 2022, pp. e259–62. EBSCOhost, https://doi.org/10.1097/INF.0000000000003515.
APA
Eichholz, T., Arendt, A.-M., Holzer, U., Seitz, C., Rabsteyn, A., Ganzenmueller, T., Klein, R., Walz, J., & Lang, P. (2022). Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy. Pediatric Infectious Disease Journal, 41(6), e259–e262. https://doi.org/10.1097/INF.0000000000003515
Chicago
Eichholz, Thomas, Anne-Marie Arendt, Ursula Holzer, Christian Seitz, Armin Rabsteyn, Tina Ganzenmueller, Reinhild Klein, Juliane Walz, and Peter Lang. 2022. “Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy.” Pediatric Infectious Disease Journal 41 (6): e259–62. doi:10.1097/INF.0000000000003515.